The surge in AI-driven drug discovery partnerships highlights a transformative shift in pharma, promising faster, cost-effective innovation.

The post Takeda and Insilico ink $600M AI drug discovery agreement appeared first on Crypto Briefing.

By

Leave a Reply

Your email address will not be published. Required fields are marked *